Pressure ulcer/injury classification today: An international perspective.

Assessment Classification Diagnosis Pressure injury Pressure ulcer Reliability Skin Validity Wound

Journal

Journal of tissue viability
ISSN: 0965-206X
Titre abrégé: J Tissue Viability
Pays: England
ID NLM: 9306822

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 06 04 2020
accepted: 28 04 2020
pubmed: 18 5 2020
medline: 15 4 2021
entrez: 17 5 2020
Statut: ppublish

Résumé

There has been an ongoing debate in the healthcare community about what pressure ulcers/injuries are, and how to name, define and classify them. The aim of this discussion paper is to provide a brief theoretical background about pressure ulcer/injury classification, to explain the approach the Guideline Governance Group has taken during the 2019 update of the International Guideline for 'Prevention and Treatment of Pressure Ulcers/Injuries' and to share views on how to best implement pressure ulcer/injury classification. First formal pressure ulcer/injury classifications were introduced in the 1950s and today various pressure ulcer/injury classification systems are used worldwide. Dissimilarities between commonly used classification systems may be considered a limitation that impedes clinical and scientific communication. However, the conceptual meaning of pressure ulcer/injury categories described within the various classification systems is comparable and the current evidence does not indicate that one classification is superior to another. Therefore, the Guideline Governance Group created a crosswalk of the major pressure ulcer/injury classifications in common use across different geographic regions. Clinicians are encouraged to use the classification system adopted by their healthcare setting in the most consistent way. The validity of pressure ulcer/injury classification is closely linked to its intended purpose. Studying measurement properties of pressure ulcer/injury classification systems must follow state-of-the-art methods. Structured educational interventions are helpful for improving diagnostic accuracy and reducing misclassification of pressure ulcers/injuries. Implementation of innovative skin and soft tissue assessments and revised pressure ulcer/injury classifications are only worth implementing, when the diagnostic information improves clinical care.

Identifiants

pubmed: 32414554
pii: S0965-206X(20)30073-5
doi: 10.1016/j.jtv.2020.04.003
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

197-203

Informations de copyright

Copyright © 2020 Tissue Viability Society. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest All authors were part of the Guideline Governance Group overseeing the development of the International Guideline for ‘Prevention and Treatment of Pressure Ulcers/Injuries’ 2019.

Auteurs

Jan Kottner (J)

Charité-Universitätsmedizin Berlin, Department of Dermatology and Allergy, Germany; Ghent University, Faculty of Medicine and Health Sciences, Belgium. Electronic address: jan.kottner@charite.de.

Janet Cuddigan (J)

University of Nebraska Medical Center, College of Nursing, Omaha, NE, USA.

Keryln Carville (K)

Silver Chain Group and Curtin University School of Nursing, Midwifery and Paramedicine, Australia.

Katrin Balzer (K)

University of Lübeck, Nursing Research Unit, Germany.

Dan Berlowitz (D)

Center for Healthcare Organization and Implementation Research (CHOIR), Bedford VA Hospital, Bedford and Boston University School of Medicine, MA, USA.

Susan Law (S)

Princess Margaret Hospital, Hong Kong.

Mary Litchford (M)

CASE Software & Books, Greensboro, USA.

Pamela Mitchell (P)

Christchurch Hospital, New Zealand.

Zena Moore (Z)

Royal College of Surgeons in Ireland, Dublin, Ireland; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; Department of Public Health, Faculty of Medicine and Health Sciences, UGent, Ghent University, Belgium; Lida Institute, Shanghai, China; Cardiff University, Cardiff, Wales, United Kingdom.

Joyce Pittman (J)

University of South Alabama, Mobile, AL, USA.

Dominique Sigaudo-Roussel (D)

University of Lyon, National Scientific Research Center (CNRS), UMR 5305, Laboratory of Tissue Biology and Therapeutic Engineering, Lyon, France.

Chang Yee Yee (CY)

Singapore General Hospital, Singapore.

Emily Haesler (E)

Curtin University, School of Nursing, Midwifery and Paramedicine, Australia; LaTrobe University, Australian Centre for Evidence Based Aged Care, School of Nursing and Midwifery, Australia; Australian National University, ANU Medical School, Academic Unit of General Practice, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH